NATASHA RICHESIN: Open Payments
NPI 1528731502 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 38 payments from 11 companies in 2025. Trend: 2023 $881 · 2024 $926 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $160 |
| Novartis Pharmaceuticals Corporation | 6 | $157 |
| PFIZER INC. | 6 | $127 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Exact Sciences Corporation | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| SANOFI PASTEUR INC. | 1 | $20 |
Products named: LEQVIO, PREVNAR 20, Wegovy, GVOKE HYPOPEN, Ozempic, Cologuard Collection Kit, XIFAXAN, ELIQUIS.
Industry payments across TN — which companies pay providers there.
